Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Health products
Remove filter for
Type: Public advisory
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 38 items.
Unauthorized blood glucose (sugar)-reading smartwatches may pose serious health risks to people with diabetes
AlertPublic advisory | 2023-11-29
Shortage of Nitroglycerin Sprays and Tablets in Canada
AlertPublic advisory | 2023-11-10
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Potential contamination of health products manufactured by Eco-Med Pharmaceuticals Inc. may pose health risks to Canadians
AlertPublic advisory | 2021-12-20
Ivermectin not authorized to prevent or treat COVID-19; may cause serious health problems
AlertPublic advisory | 2021-10-19
Recall: One lot of Riva-Risperidone 0.25 mg tablets recalled due to a packaging error
AlertPublic advisory | 2021-10-09
Two lots of Novo-Gesic Forte/Acetaminophen recalled due to labelling error that may lead to overdose and in the most severe cases, death
AlertPublic advisory | 2021-10-06
One lot of Mirvala 28 birth control pill recalled
AlertPublic advisory | 2021-09-30
Graphene face masks
AlertPublic advisory | 2021-09-28
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
AlertPublic advisory | 2021-09-25
Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy
AlertPublic advisory | 2021-08-06
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
AlertPublic advisory | 2021-06-29